
|Videos|January 6, 2022
Urology Times 50 Innovations Series: PSA testing
Author(s)Urology Times staff
"The fact that it was a simple blood test, it was absolutely objective, and it was…non-invasive…made it very attractive," says William J. Catalona, MD.
Advertisement
As part of the Urology Times' 50th Anniversary Innovation Celebration, William J. Catalona, MD, discusses how prostate-specific antigen (PSA) testing has greatly impacted the field of urology over the past 50 years. Catalona is a professor of urology at Northwestern University in Chicago, Illinois.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
2
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
3
Kari Tikkinen, MD, PhD, discusses POISE-3 findings on tranexamic acid in urologic surgery
4
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
5
















































